Vivoryon Therapeutics N.V.

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 10 aug 2015 - 08:04

Statutaire naam Vivoryon Therapeutics N.V.

Titel Probiodrug to present at Canaccord Genuity 35th Annual Growth Conference in Boston

Bericht HALLE/SAALE, Germany, 10 August 2015 - Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing novel therapeutic solutions to treat Alzheimer's disease, announces that Dr Konrad Glund, CEO of Probiodrug, is scheduled to present at the Canaccord Genuity 35th Annual Growth Conference. The conference is being held in Boston, MA, at the InterContinental from the 12th to the 13th August 2015.

Vorige register resultaat

Volgende register resultaat

Gerelateerde downloads

201508100000000006_Probiodrug to present at Canaccord Genuity 35th Annual Growth Conference in Boston.pdf (opens in a new window)

Datum laatste update: 28 juli 2024